Nucleophosmin (Dako Omnis)
- Monoclonal Mouse Anti-Human
No data to display
This product is not available for purchase by the general public.
Product Details
Features
- Optimized staining performance of both high and low-expression structures
- Dako Omnis and the dynamic gap staining technology provides a consistent, uniform staining with excellent morphology
- Crisp and clear staining with no background
- Optimal laboratory efficiency with ready-to-use antibodies on Dako Omnis
- The staining performance of all FLEX RTU antibodies has been defined, tested and approved through collaboration with leading, international pathology experts.
Specifications
| Application |
|
| Clone |
|
| Code Number |
|
| Immunogen |
|
| Isotype |
|
| Reagent Provided |
|
| Solutions |
|
| Species |
|
| Specificity |
|
Literature
- Catalogs
-
Atlas of Controls
The Atlas of Controls illustrates the staining performance of each antibody in the FLEX Ready-to-Use system.
- Catalogs
- English
- 26 Mar 2024
- 37.78 MB
- Technical Overviews
Support
- Instructions for Use
-
Featured References
- Product Description References
-
1. Falini B, Mecucci C, Tiacci E, Alcaly M, Rosatin R, Pasqualucci L, et al. Cytoplasmic nucleophosmin in acute myologenous leukemia with a normal karyotype. New Engl J Med 2005,352:254-66.
2. Falini B, Bolli N, Shan J, Martelli PM, Liso A, Pucciarini A, et al. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. Blood 2006,107:4514-23.
3. Pasqualucci L, Liso A, Martelli MP, Bolli N, Pacini R, Tabarrinni A, et al. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification. Blood 2006: Epub. ahead of print.
Promotions